Skip to main content
. 2020 Aug;18(4):e418–e442. doi: 10.1016/j.clgc.2019.12.004

Supplemental Table 7.

Primary HRQoL Regression

Variable Coefficient SE z P > z 95% CI
EQ5D score baseline 0.5967924 0.0406532 14.68 .000 0.5171136 to 0.6764713
Patient gender 0.0521357 0.0179587 2.90 .004 0.0169372 to 0.0873341
Age category, y
 50-59 −0.0187366 0.0338184 −0.55 .580 −0.0850194 to 0.0475462
 60-69 −0.0039931 0.0318242 −0.13 .900 −0.0663674 to 0.0583812
 70-79 −0.0108462 0.0331665 −0.33 .744 −0.0758513 to 0.0541589
 > 80 −0.0243156 0.0396575 −0.61 0.540 −0.1020428 to 0.0534116
BMI category
 Overweight −0.0100358 0.0166613 −0.60 0.547 −0.0426913 to 0.0226198
 Obese −0.0069584 0.0182376 −0.38 0.703 −0.0427036 to 0.0287867
 Morbidly obese −0.0652968 0.0651534 −1.00 0.316 −0.1929952 to 0.0624015
Smoking status
 Previous −0.0033888 0.0148166 −0.23 0.819 −0.0324288 to 0.0256512
 Current −0.0069576 0.0239007 −0.29 0.771 −0.0538022 to 0.039887
ECG result −0.0057031 0.016846 −0.34 0.735 −0.0387207 to 0.0273145
Celecoxib treatment −0.0010674 0.0136832 −0.08 0.938 −0.0278859 to 0.0257511
Diabetes −0.0989409 0.0252237 −3.92 0.000 −0.1483784 to −0.0495034
TCC history −0.015477 0.0155777 −0.99 0.320 −0.0460086 to 0.0150547
Year
 2 −0.0250881 0.0103193 −2.43 0.015 −0.0453134 to −0.0048627
 3 −0.0107493 0.0102873 −1.04 0.296 −0.0309119 to 0.0094134
Tumor recurrence
 Unknown 0.0334809 0.0823301 0.41 0.684 −0.1278831 to 0.1948449
 Grade 1 0.062 0308 0.0555815 1.12 0.264 −0.046907 to 0.1709685
 Grade 2 0.0518003 0.0339202 1.53 0.127 −0.014682 to 0.1182826
 Grade 3 −0.0830612 0.0258832 −3.21 0.001 −0.1337914 to −0.0323311
Progression −0.0990853 0.037488 −2.64 0.008 −0.1725605 to −0.0256102
Progression history 0.0043892 0.0516379 0.08 0.932 −0.0968193 to 0.1055976
Constant 0.3218822 0.0489321 6.58 0.000 0.225977 to 0.4177873

Abbreviations: BMI = body mass index; CI = confidence interval; ECG = electrocardiography; EQ-5D = EuroQoL 5 dimension; HRQoL = health-related quality of life; SE = standard error; TCC = transitional cell carcinoma.